Toxicity of 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin (TCDD)
- 1 January 1982
- journal article
- review article
- Published by Taylor & Francis in Drug Metabolism Reviews
- Vol. 13 (3), 387-406
- https://doi.org/10.3109/03602538209029986
Abstract
In summary, the toxicity of TCDD has been comprehensively examined in multiple acute, subchronic, and chronic studies. Acute toxicity studies have shown marked species differences, with up to a 10,000-fold difference between the single oral LD50 dose for the guinea pig and hamster. TCDD is capable of causing an acnegenic response in man and a similar skin response in certain animals. It is also a potent inducer of microsomal enzymes in some but not all species. A dose-related suppression of cell-mediated immunity has been observed at higher dose levels in laboratory animals but not in humans manifesting TCDD-induced acnegenic response. TCDD causes a dose-related teratogenic response in mice, with the no-adverse-effect level of 0.1 micrograms TCDD/kg/day. In rats, TCDD causes embryo- and fetotoxicity above the no-adverse-effect level of 0.03-0.125 micrograms/kg/day. Dose-related reproductive effects have also been noted in monkeys at doses that elicit maternal toxicity, and additional long-term studies are presently underway. A multigeneration reproduction study as well as a lifetime chronic toxicity study have been completed with TCDD in rats; in both studies, the no-adverse-effect level was found to be 0.001 microgram TCDD/kg/day. Numerous mutagenic studies have been performed using in vitro plant and microbial test systems as well as in vivo tests in mammals and man. A mutagenic response was noted in a few of the vitro test systems, but there are no definitive in vivo correlates of TCDD mutagenicity in higher mammals or man. TCDD has been studied for carcinogenic potential in rats and mice. There is good correlation of the results, with a carcinogenic response noted in both species only after long-term ingestion of higher dose levels that induce toxicity. No carcinogenic response occurred at continuous dose levels of 0.001-0.0014 micrograms/kg/day in rats and 0.001-0.03 micrograms/kg/day in mice. Data presently available are more supportive of a nongenetic (?promotor) rather than a genetic mechanism of carcinogenesis. The most recent research, some of which is still underway, indicates that the biologic uptake and toxicity of TCDD may be significantly decreased if the TCDD is adsorbed onto carbon or soil particles. This information is helpful in hazard assessment of exposure to TCDD.Keywords
This publication has 39 references indexed in Scilit:
- 2,3,7,8-Tetrachlorodibenzo-p-dioxin: Acute oral toxicity in hamstersToxicology and Applied Pharmacology, 1981
- Trace Chemistries of Fire: A Source of Chlorinated DioxinsScience, 1980
- Toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the Golden Syrian hamsterToxicology and Applied Pharmacology, 1980
- Chlorinated dibenzo-p-dioxins and related compounds in incinerator effluentsChemosphere, 1980
- TOXICOPATHOLOGY CHARACTERISTICS OF THE HALOGENATED AROMATICSAnnals of the New York Academy of Sciences, 1979
- The comparative toxicity of chlorinated dibenzo-p-dioxins in mice and guinea pigsToxicology and Applied Pharmacology, 1978
- Toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rhesus monkeys (Macaca mulatta) following a single oral doseToxicology and Applied Pharmacology, 1978
- Toxicity of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin in larval and adult forms ofRana catesbeianaBulletin of Environmental Contamination and Toxicology, 1976
- Toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) inToxicology and Applied Pharmacology, 1974
- Toxicology of chlorinated dibenzo-p-dioxins.Environmental Health Perspectives, 1973